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ABSTRACT
Huntington’s disease (HD) is associated with protein aggregates that also hallmark almost 
all the major neurodegenerative diseases known. The aggregate formation is thought to be 
initiated by small polyglutamine (polyQ) peptides, which act as “seeds” for aggregation 
of polyQ stretch containing proteins within the cell. It has also been suggested that polyQ 
peptides or aggregates can be released from cells and that this extracellular polyQ material 
next can enter the neighbouring cells. The infiltration of these extracellular peptides further 
acts as seeds for aggregation and hence a prion-like propagation of the disease follows. 
Here, we show that intracellular overexpression of DNAJB6 and various members of 
the HSPB family, which are established to be suppressor of polyQ aggregation initiated 
by intracellular expressed polyQ fragments, fail to prevent this “induced” intracellular 
aggregation by extracellular polyQ seeds. Our data not only confirm previous in vitro findings 
that DNAJB6 inhibits polyQ aggregation at a very early step, but also suggest that aggregate 
initiated or triggered by extracellular polyQ material requires handling different than that from 
aggregates initiated by intracellular polyQ fragments.
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INTRODUCTION
Polyglutamine diseases (polyQ) are a set of neurodegenerative diseases (Huntington’s disease; 
HD, several spinocerebellar ataxias; SCA, and spinal bulbar muscular atrophy ; SBMA) that are 
characterized by expanded glutamine (CAG) repeats beyond a certain threshold in different 
genes (1,2). The expanded polyQ stretch in the corresponding disease-related proteins has 
a propensity to aggregate through forming highly ordered β-sheet rich structures commonly 
referred to as “amyloids” (3,4). Although not yet precisely clear how, but aggregate formation is 
suggested to be the basis of disease initiation. How aggregate formation is initiated (and hence 
what determines the onset of neurodegeneration) is still not fully understood. However, several 
lines of evidence indicate that activation of proteases that subsequently cleave full length polyQ 
proteins, that themselves are not very aggregation-prone, into smaller fragments is required (5–
7). These small fragments containing the CAG expansion next can act as aggregation seeds 
and nucleate the aggregation of other polyQ containing full length proteins (8–10).  
Heat shock proteins (HSPs) by virtue of their function as molecular chaperones act as the first 
line of defence in against protein aggregation. By their binding to un-or misfolded proteins, 
they not only can facilitate proper protein folding but also assist in protein clearance (11–13). In 
dedicated screens for members of the HSP families that might be good suppressors of polyQ 
aggregation, a number of very effective HSPs were identified, especially within the DNAJ and 
HSPB family, with DNAJB6 and DNAJB8 to be the most potent (14,15). In particular, we found 
that DNAJB6 not only prevents polyQ mediated aggregation in cells (14), simple organisms (16) 
but also but also delays aggregation and disease initiation in mice  (Kakkar et al., submitted). 
The remarkable potency of DNAJB6 was suggested to be related to its ability to bind to small 
polyQ peptides (“the seeds”), hereby prevent the initiation of the aggregation reaction (17). 
Indeed, DNAJB6 also directly suppressed aggregation of polyQ peptides generated internally 
in living cells (18). 
Recently, it has been suggested that for polyQ diseases, like for many other neurodegenerative 
diseases, aggregates may be transmitted from cell-to-cell and spread throughout the brains 
in a prion like mechanism (19). Indeed, synthetic polyQ peptides form filamentous aggregates 
and can be internalized by mammalian cells in culture, and gain access to the cytoplasmic 
compartments where they can act as potential “aggregate seeds” (20,21). 
In this study, we wondered whether the members of various HSP families that can prevent 
polyQ aggregation initiated by intracellularly expressed polyQ peptides also would be able 
to prevent aggregation induced by these extracellular-polyQ peptides. Unexpectedly, all the 
combinations of chaperones tried in this study failed to prevent the aggregation initiated by 
extracellular polyQ.
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RESULTS
Extracellular Q-peptides can seed the aggregation of cytoplasmic Htt-polyQ proteins
As previously suggested, extracellular Q-peptide can be internalized in cells and trigger the 
aggregation of even non-pathogenic polyQ repeat proteins (21). To be able to test effects on 
chaperones on such a seeding effects, we first had to establish a reliable (semi) quantitative 
assay using our HEK293 FRTTO cells in which we can precisely regulate the induction of 
these chaperones (14). Hereto, the HEK293 cells were transfected with plasmids encoding 
the exon1 fragment of the Huntingtin protein (Htt)  with 23, 53 or 74 Q-repeats fused to GFP 
(HttQ23-eGFP, HttQ53-eGFP and HttQ74-eGFP respectively). 48 hours after expression, 
HttQ23-eGFP and HttQ53-eGFP did not form any detectable aggregates whilst expression of 
HttQ74-eGFP had resulted in formation of protein aggregates that could be trapped as SDS 
insoluble material on cellulose acetate filters (Fig. 1A) or could be detected in the stacking 
of SDS-PAGE gels (Fig. 1B). The addition of extracellular Q-peptides (Q30 or Q45) not only 
worsened the aggregation of HttQ74-eGFP but also lead to the formation of intracellular 
aggregates of HttQ53-eGFP and of the non-pathogenic HttQ23-eGFP (Fig. 1A, B).  Also, 
immunochemically the aggregates were visible for all the three constructs used with the 
addition of Q45 peptide (Fig. 1C). Aggregates in Fig. 1 were detected using a GFP antibody. 
As a control, we also used an anti-polyQ antibody 1C2, which confirmed the data with the GFP 
antibody (Fig. S1) and which also showed that the extracellular Q-peptide did not seed the 
aggregation of eGFP. This confirms that the Q-peptides act by nucleating the aggregation 
of (other) polyQ proteins, and not by aspecific overload of the cellular chaperone capacity 
of the cell (Fig. 1A & 1B). 
Extracellular Q-peptides co-localize with aggregated cytoplasmic Htt-polyQ protein
To further ascertain whether extracellularly applied Q-peptides indeed are in contact with and 
hereby seed the internal polyQ repeat constructs, we used Alexa-550 tagged extracellular 
Q-peptides. Whilst inclusion of extracellular Q45 peptides without intracellular HttQ23-eGFP 
or HttQ74-eGFP could be detected (red signal), most HttQ74-eGFP and all HttQ23-eGFP 
aggregates were positive for the Q-peptides (Fig. 2), further suggesting that Q45 peptides 
can enter the cells and get access to the cytosolic compartment to act in a prion-like manner 
conferring a heritable phenotype on cells expressing the non-pathogenic homologous 
protein.
DNAJB6 fails to prevent extracellular polyQ-peptide mediated “induced” aggregation of 
Htt-polyQ constructs 
Using the current setup, we next asked whether  DNAJB6, as one of the most potent HSP 
family member to protect aggregation of intracellular polyQ fragments (14,17), also would be 
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Fig. 1: Extracellular Q-peptide “seeds” aggregation of cytoplasmic Htt-polyQ proteins
(A) Filter trap assay of HEK 293 cell extracts overexpressing different Htt-exon1-polyQ lengths. Q-peptides were added 
to the culture medium during 48 hours. Serial five-fold dilutions were loaded on cellulose-acetate membranes and 
probed with anti-GFP antibody. (B) SDS-PAGE with stacking gel (showing aggregates) was performed to check for the 
expression of Htt-exon-1 polyQ constructs. (C) Representative confocal pictures of cells transfected with HttQ23-eGFP 
or HttQ74-eGFP (green) incubated without and with Q-peptides. Q45 was added to the medium during 24 hours. DAPI 
staining is shown in blue. Bar represents 20μm.
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able to prevent the polyQ aggregation induced by these extracellular-polyQ peptides. 1uM 
of extracellular polyQ-peptide was added to cells one day after transfection with the HttQ23-
GFP or HttQ74-GFP and the molecular chaperones and the amount of aggregates were 
followed in time in which DNAJB6 was either turned on or not (Fig. 3). No aggregates were 
detected for cells expressing HttQ23-GFP alone. However, the addition of Q-peptides already 
leads to the co-aggregation with HttQ23-GFP within a few hours. To our surprise, DNAJB6 
completely failed to prevent extracellular polyQ peptide mediated induced aggregation of 
HttQ23-eGFP even at the early time points although it completely suppressed formation by 
intracellular HttQ74-eGFP aggregates without addition of extracellular polyQ peptide (Fig. 3). 
Most of the members of different chaperone families fail to prevent the polyQ-peptide 
mediated “induced” aggregation of Htt-polyQ constructs 
Since we did not find any effect of DNAJB6 on seeding effect of extracellular polyQ peptides, 
we wondered if other chaperones might work in this setup. As DNAJB6 is thought to act at an 
early stage of aggregation initiation by peptides, we argued that its failure to act on seeding 
via extracellular peptides might be due to the fact that these enter the cells after released into 
Fig. 2: Co-localization of extracellular polyQ peptides with cytosolic Htt-polyQ protein
Representative confocal pictures of HEK293 cells transfected with HttQ23-eGFP or HttQ74-eGFP (green) incubated 
with Alexa550 (red) labelled extracellular Q45 polyQ-peptides. Overlay shows that most of the extracellular polyQ 
peptide co-localize with HttQ23/Q74-eGFP. DAPI staining is shown in blue. Bar represents 20μm.
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Fig. 3: DNAJB6 is unable to prevent the “induced” aggregation of HttQ23/Q74-eGFP via extracellular polyQ 
peptides.
(A) Filter trap assay of cell extracts at indicated time points. Serial five-fold dilutions were loaded on cellulose-acetate 
membranes and probed with anti-GFP antibody. For control condition, co-transfection of HttQ74-GFP -/+ DNAJB6 is 
shown without the addition of extracellular peptide. (B) Western Blot assay of cell extracts at indicated time points. 
Nitro cellulose membranes were probed with the indicated antibodies. (C) Representative confocal pictures of cells 
co-transfected with DNAJB6 and HttQ23-eGFP or HttQ74-eGFP (green). One day after transfection the cells were 
incubated without and with Q45 added to the medium during 1 day. DAPI staining is shown in blue. Bar represents 
20μm.
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the cytosol in a fibrillar state that is beyond control of DNAJB6 (17). Based on our previous 
work (14,15,22), we selected a number of chaperones and tested their effect on intracellular 
aggregate nucleation by extracellular polyQ peptides. Strikingly, none of them showed even 
the slightest reduction in polyQ aggregation in the current setup (Fig. 4A, left column). 
Since most of the selected chaperones are thought to work within the context of the central 
Hsp70 machinery, we also combined their overexpression by co-expressing with HSPA1A, 
the main stress inducible Hsp70 family member.  Yet, neither HSPA1A overexpression alone 
nor in combination with any of the selected chaperone members protected against induced 
aggregation of the HttQ23-GFP by the extracellular Q45 peptide (Fig. 4A, right side panel).
DISCUSSION
Although more and more evidence is indicating that in some neurodegenerative diseases 
like Alzheimer’s disease and Parkinson’s disease aggregates may transfer from neuron to 
neuron and show have a prion-like infectivity (23,24) this is  still less clear for polyQ diseases 
like Huntington’s disease. Yet, the fact that synthetic polyQ peptides form filamentous 
aggregates and are internalized by mammalian cells in culture, and gain access to the 
cytoplasmic compartments where they can act as potential “aggregate seeds” at least 
suggests that also polyQ  disease may spread in a prion-like manner (20,25).
In the current study, we confirmed that extracellular polyQ peptides indeed can infiltrate cells 
and initiate the aggregation of the intracellular polyQ proteins, even those that normally would 
not aggregate supporting that a prion like-propagating may also play a role in diseases like 
HD. 
Strikingly, however, the seeding of intracellular aggregation by these added extracellular 
Q-peptides is beyond the control of chaperones that previously were shown to have potency 
to prevent intracellular polyQ aggregates. This includes DNAJB6 that was shown to be most 
potent suppressor of polyQ mediated aggregation (14). The failure of DNAJB6 in preventing 
this nucleation effect might be attributed to the fact that DNAJB6 was mainly found to prevent 
the initiation of “seeding effect” mediated by polyQ peptides and not on aggregate elongation 
by preformed aggregates (14,17). The external polyQ peptide probably already enters in 
a fibrillated state (so preformed intermediate aggregate moiety), which renders DNAJB6 
incapable to handle it and hence the aggregation cascade takes place. Our findings that the 
aggregation process indeed is so fast (see Fig. 3) indeed suggest they must have entered 
the cells as pre-seeds since aggregate initiation by Q-peptides are usually characterized 
by long lag-phases (17). Inversely, these results thus indirectly also validate the point that 
DNAJB6 is indeed an “early stage” polyQ aggregate mediator. 
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Fig. 4: Members of different chaperone families fail to prevent the polyQ-peptide mediated “induced” aggregation 
of Htt-polyQ constructs
(A) Filter trap assay of HEK 293 cell extracts co-expressing HttQ23-eGFP and different chaperones with (right side) or 
without (left side) HSPA1A with 1uM of Q45 peptide added. As a control HttQ23-eGFP was co-expressed with HSPA1A 
without any peptide (upper most row). Serial five-fold dilutions were loaded on cellulose-acetate membranes and 
probed with anti-GFP antibody. Post-lysis control (PLC) was also used (preparation described in the method section). 
(B) SDS-PAGE with stacking gel (showing aggregates) and soluble fractions was performed to check for the expression 
of Httexon-1 polyQ constructs. Corresponding antibodies were used to check for the expression of various chaperones.
The seeds also seem to be beyond control of HSPB1 and HSPB5 of which it had been 
suggested that they may delay fibril elongation in vitro (26), although it must be stated that 
we never found these HSPB members to be very effective in delaying aggregation initiated 
intracellular polyQ fragment (15). The failure of DNAJB2 to act on aggregate seeding 
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by extracellular peptides or fibrils  suggest that also chaperoning the pre-seeds to the 
proteasome, in which this chaperone is thought to be involved (27,28), may not be possible. 
Maybe most surprisingly, chaperones like HSPB7 or the HSPB8/BAG3 complex that reduced 
intracellular polyQ aggregation by stimulating aggregate clearance through the autophagic 
machinery (15,29) were also ineffective and even overexpression of the FOXO1 that induces 
an entire repertoire of chaperones, proteases (Ying et al., manuscript in preparation) and 
that enhances autophagy (30,31), could not prevent aggregate formation initiated by 
extracellular peptides (Fig. 4A & 4B).
Together, this implies that if cell-to-cell transmission indeed plays a role in the progression 
of CAG repeat disease, upregulation of endogenous protein quality control systems may no 
longer suffice. Interestingly, we recently found in a cohort of SCA3 patients that whereas age 
at onset was clearly associated with CAG repeat length (and thus intracellular aggregation 
initiation), the rate of progression of the disease was not (Verbeek et al., manuscript in 
preparation). Together with our demonstration that DNAJB6 can actually delay the onset 
of disease in a Huntington mouse model (Kakkar et al., submitted), this would imply that 
initiation of disease (CAG dependent, chaperone dependent) and progression of disease 
(cell-to-cell transmission, immune response) may be partially independent, albeit that these 
are still interrelated processes.
MATERIAL & METHODS
Cell line, culture and transient transfections
Hek293 stably expressing the flp-in expression vector and a tetracycline (tet) repressor 
(Flp-In T-REx HEK-293, Invitrogen) are grown in DMEM (Invitrogen/Gibco, cat no 41966-
052) supplemented with 10% foetal bovine serum (Greiner bio-one, cat no 758093) and 100 
units/ml penicillin and 100 µg/ml streptomycin (Invitrogen, cat no 15140-163). Furthermore 
they are kept under selective pressure to retain the tetracycline repressor and the Flp-in 
recombination site by adding 5 µg/ml Blasticidine (Invitrogen, cat no A11139-03) and 100 
µg/ml of Zeocin (Invitrogen, cat no R250-01) to the culture medium. Cultures were maintained 
at 37°C and 5% CO2 in a humidified incubator. 
For transient transfections, cells were grown to 50-60% confluence in 35 mm-diameter 
dishes coated with 0.001% of poly-L-lysine (Sigma, P8920) and/or on coated coverslips 
for (confocal) microscopy analysis. Cells were transfected with a total of 1ug DNA using 
Lipofectamine (Gibco) according to the manufacture instructions. To induce expression of 
the pcDNA5/FRT/TO vectors tetracycline was added to the medium in a final concentration 
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Gene cloning 
For the experiments plasmids were used driving the expression of a fragment of exon1 of 
Huntingtin with different sizes of polyQ fused to eGFP. peGFP-HttQ23 and peGFP-HttQ74 
were kindly provided by David Rubinsztein, Cambridge, UK. Tetracycline inducible V5-
tagged pcDNA5/FRT/TO plasmids encoding for the expression of several heat shock 
proteins were constructed as described in Hageman et al., 2010 (14).
Addition of Q-peptides
PolyQ-peptides (K2Q30K2, K2Q45K2) were obtained from R. Melki, Gif-sur-Yvette, France 
and were generated as described in (21) . Stock solutions of Q30 and Q45 peptides with 
a concentration of 100 uM in Hepes buffer (Hepes 20 mM/NaCl 150 mM/pH=7.5) or tris 
buffer (tris-HCl 20 mM/NaCl 150 mM/pH=7.4) were kept at 4oC. Prior to addition to the 
cell culture the stock solution was mixed thoroughly by vortexing and pipetting repeatedly. 
Sonication appeared to reduce the co-aggregation. Addition to the culture medium to a 
final concentration of 1uM was done one day after transfection with the HttQ23-GFP and the 
molecular chaperones. For microscopy Q45 peptides tagged with Alexa 550, dissolved in 
tris buffer were added to the culture medium on the coverslip to a final concentration of 1uM. 
For most experiments the incubation time with the Q-peptides was 24 hours in the incubator 
at 37°C and 5% CO2.
Post-lysis control 
Since the Q-peptides tended to co-aggregate very fast with the HttQ23-GFP a post-lysis-
control was carried out in each experiment to verify the obtained aggregates were formed 
during the cell culture in living cells and not afterwards in the test tube. Briefly Q-peptides 
were added to a cell lysate of cells transfected with Htt-Q23-GFP (2 days after transfection) 
in a final concentration of 0.2 um. Hereafter the mixture was sonicated and treated in the 
same way as the samples.
Cell extracts and samples preparation
24 or 48 hours after transfection and Q-peptides addition the medium was washed away 
with PBS from the monolayer thoroughly in order to wash away the Q-peptides as much as 
possible. Cells were scraped in FTA-buffer (10 mM Tris-Cl pH 8.0, 150 mM NaCl) + 2% SDS 
and sonicated. Protein content was determined with the DC protein assay (Bio-RAD). Western 
blot samples were prepared at a final concentration of 1µg/µl in SDS-PAGE loading buffer 
and heated for 5 min at 100 ºC. Filter trap samples were prepared at a final concentration of 
100 ng/µl, 20 ng/µl and 4 ng/µl in FTA buffer with 2%SDS and 50 mM dithiothreitol and heated 
for 5 min at 100 ºC. Samples were used immediately or kept frozen at -20ºC.
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Western blot analysis
Equal amounts of protein were loaded on 12.5% or 16% SDS-PAGE gels. Proteins were 
transferred onto nitrocellulose membranes and probed with mouse anti-GFP antibody JL-8 
(Clontech) at a 1:5000 dilution, mouse anti-V5 antibody (Invitrogen) at a 1:5000 dilution. 
GAPDH was used a loading control and was detected with a mouse antibody (RDI Research 
Diagnostics) at 1:10000 dilution. To visualize the Q-peptides detection was done on a 16% 
SDS-PAGE gel with a polyglutamine mouse monoclonal antibody 1:2000 (3B5H10, Sigma). 
This antibody does only react with soluble polyglutamine. Blots were subsequently incubated 
with HRP-conjugated anti-mouse secondary antibody (Amersham) at 1:5000 dilution and 
visualization was performed with Enhanced Chemiluminescence and Hyperfilm (ECL, 
Amersham). In most cases the stacking gel was analysed in parallel to detect the High 
Molecular Weight (HMW) fraction of aggregated HttQ23-GFP and Q-peptides.
Filter trap assay
To determine protein aggregates, the filter trap assay was performed as previously 
described (14). Briefly, 10, 2 and 0.4 µg of protein extracts were applied onto 0,2 µm pore 
Cellulose Acetate membrane prewashed with FTA + 0.1% SDS. Mild suction was applied 
and the membrane was washed 3 times. Aggregated proteins trapped in the membrane 
were probed with mouse anti-GFP antibody JL-8 (Clontech) at a 1:5000 dilution and mouse 
anti-polyglutamine antibody (Sigma) at a 1:5000 dilution followed by HRP-conjugated anti-
mouse secondary antibody (Amersham) at 1:5000 dilution. Visualization was performed 
using enhanced chemiluminescence and Hyperfilm (ECL, Amersham). 
Possible blocking of the cellulose acetate membrane by the Q-peptides and, as a result, 
preventing soluble HttQ23-GFP to pass through the membrane was checked by applying 
first a sample with Q-peptides and hereafter a sample with HttQ23-GFP. Only minor blockage 
was observed.
Confocal microscopy
24-48 hours after transfection and Q-peptides addition the medium was washed away 
with Phosphate-Buffered Saline (PBS) from the monolayer thoroughly and the cells were 
fixed with 3.7% formaldehyde for 15 minutes and hereafter were washed three times with 
PBS. To visualize nuclei, cells were stained 10 minutes with 0.2 µg/ml 4’,6-diamidino-2-
phenylindole (DAPI). Coverslips were mounted in Citifluor. Images of Alexa-550, GFP and 
DAPI fluorescence were obtained using the Leica confocal laser scanning microscope 
(Leica TCS SP2, DM RXE) with a 63X/1.32 oil lens. The captured images were processed 
using Leica Confocal Software and Adobe Photoshop.
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SUPPLEMENTARY INFORMATION – CHAPTER 4
Fig. S1: Western Blot assay of cell extracts at indicated time points and conditions. 
Nitro cellulose membranes were probed with the polyQ antibody 1C2 as an additional check corresponding to Fig. 1 
(A), Fig. 3 (B) and Fig. 4 (C).
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